Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL

  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • López, Cristina
  • Clot, Guillem|||0000-0003-2588-7413
  • Nadeu, Ferran|||0000-0003-2910-9440
  • Grau Vorster, Marta|||0000-0003-3779-0387
  • Frigola, Gerard|||0000-0001-6794-6456
  • Bosch-Schips, Jan
  • Radke, Josefine
  • Ishaque, Naveed|||0000-0002-8426-901X
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Luizaga Velasco, Luis|||0000-0001-9314-5783
  • Barcena, Carmen
  • Kelleher, Nicholas|||0000-0003-4610-2718
  • Villamor, Neus|||0000-0001-6538-4111
  • Baumann, Tycho|||0000-0003-4421-0088
  • Muntañola, Ana|||0000-0001-7839-6648
  • Sancho-Cia, Juan M.
  • Martín García-Sancho, Alejandro|||0000-0001-6330-1028
  • González Barca, Eva|||0000-0002-1323-1508
  • Matutes, Estella|||0000-0001-6745-7046
  • Brito, Jordi A.
  • Karube, Kennosuke
  • Salaverria Frigola, Itziar|||0000-0002-2427-9822
  • Enjuanes, Anna|||0000-0002-4679-6687
  • Wiemann, Stefan|||0000-0003-4683-3174
  • Heppner, Frank L.
  • Siebert, Reiner
  • Climent, Fina|||0000-0002-4360-8388
  • Campo, Elias|||0000-0001-9850-9793
  • Giné, Eva|||0000-0002-0532-1204
  • López Guillermo, Armando|||0000-0002-8588-8381
  • Bea, Sílvia|||0000-0001-7192-2385
Testicular large B-cell lymphoma (TLBCL) is an infrequent and aggressive lymphoma arising in an immune-privileged site and has recently been recognized as a distinct entity from diffuse large B-cell lymphoma (DLBCL). We describe the genetic features of TLBCL and compare them with published series of nodal DLBCL and primary large B-cell lymphomas of the CNS (PCNSL). We collected 61 patients with TLBCL. We performed targeted next-generation sequencing, copy number arrays, and fluorescent in situ hybridization to assess chromosomal rearrangements in 40 cases with available material. Seventy percent of the cases showed localized stages. BCL6 rearrangements were detected in 36% of cases, and no concomitant BCL2 and MYC rearrangements were found. TLBCL had fewer copy number alterations (p < 0.04) but more somatic variants (p < 0.02) than nodal DLBCL and had more frequent 18q21.32-q23 (BCL2) gains and 6q and 9p21.3 (CDKN2A/B) deletions. PIM1, MYD88, CD79B, TBL1XR1, MEF2B, CIITA, EP300, and ETV6 mutations were more frequent in TLBCL, and BCL10 mutations in nodal DLBCL. There were no major genetic differences between TLBCL and PCNSL. Localized or disseminated TLBCL displayed similar genomic profiles. Using LymphGen, the majority of cases were classified as MCD. However, we observed a subgroup of patients classified as BN2, both in localized and disseminated TLBCL, suggesting a degree of genetic heterogeneity in the TLBCL genetic profile. TLBCL has a distinctive genetic profile similar to PCNSL, supporting its recognition as a separate entity from DLBCL and might provide information to devise targeted therapeutic approaches.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma

  • Bolòs, Anna de
  • Carreras-Caballé, María
  • Sureda-Gómez, Marta
  • Rodríguez, Marta-Leonor
  • Charalampopoulou, Stella
  • Albero Gallego, Robert|||0000-0001-5527-0997
  • Maiques-Diaz, Alba
  • Playa-Albinyana, Heribert
  • Clot, Guillem|||0000-0003-2588-7413
  • López, Cristina
  • Colomer, Dolors|||0000-0001-7486-8484
  • Martin-Subero, José I.
  • Campo, Elias|||0000-0001-9850-9793
  • Reverter Cendrós, David|||0000-0002-5347-0992
  • Villanueva, Josep|||0000-0003-1396-9470
  • Amador, Virginia|||0000-0002-3016-2874
Mantle cell lymphoma (MCL) is considered one of the most aggressive B-cell lymphoid neoplasms. The transcription factor SOX11 is aberrantly expressed in conventional aggressive MCL, while it is not or weakly expressed in the leukemic non-nodal MCL subtype with a predominantly indolent clinical evolution. SOX11 is a key driver of MCL through the regulation of several oncogenic mechanisms, suggesting that it may be interacting with different protein complexes to exert its multiple actions. Using proteomic strategies, we characterized the SOX11-interactome and validated its physical interaction with SMARCA4, the catalytic subunit of the SWI/SNF chromatin-remodeling complex. SMARCA4 expression is directly regulated by SOX11, and its upregulation significantly associates with worse outcomes of patients. Integration of global DNA-binding and transcriptomic profiles revealed that SOX11 and SMARCA4 share binding sites enriched in open chromatin and active promoters and regulate common key oncogenic pathways crucial for MCL progression and aggressiveness. The SMARCA4-specific PROTAC-degrader AU-15330 significantly reduced SOX11 binding to specific regulatory regions and diminished the activation of BCR-, NIK-, and BCL2-signaling pathways. Moreover, SMARCA4 degradation significantly reduced proliferation and induced apoptosis of SOX11-positive MCL cells, highlighting AU-15330 as a promising therapeutic approach for patients who may relapse from current target therapies in MCL. (Figure presented.).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Unraveling the genetics of transformed splenic marginal zone lymphoma

  • Grau Vorster, Marta|||0000-0003-3779-0387
  • López, Cristina
  • Navarro, Alba|||0000-0002-4041-0974
  • Frigola, Gerard|||0000-0001-6794-6456
  • Nadeu, Ferran|||0000-0003-2910-9440
  • Clot, Guillem|||0000-0003-2588-7413
  • Bastidas-Mora, Gabriela
  • Alcoceba, Miguel|||0000-0002-3819-4846
  • Baptista, Maria Joao|||0000-0003-3471-2535
  • Blanes, Margarita
  • Colomer, Dolors|||0000-0001-7486-8484
  • Costa, Dolors|||0000-0002-8276-3292
  • Domingo-Domenech, Eva|||0000-0001-8907-090X
  • Enjuanes, Anna|||0000-0002-4679-6687
  • Escoda, Lourdes|||0000-0003-3288-9716
  • Forcada, Pilar
  • Giné, Eva|||0000-0002-0532-1204
  • López Guerra, Mónica|||0000-0002-5545-0178
  • Ramón, Olga
  • Rivas Delgado, Alfredo|||0000-0003-0385-3415
  • Folch, Laura Vicente
  • Wotherspoon, Andrew
  • Climent, Fina|||0000-0002-4360-8388
  • Campo, Elias|||0000-0001-9850-9793
  • López Guillermo, Armando|||0000-0002-8588-8381
  • Matutes, Estella|||0000-0001-6745-7046
  • Bea, Sílvia|||0000-0001-7192-2385
The genetic mechanisms associated with splenic marginal zone lymphoma (SMZL) transformation are not well defined. We studied 41 patients with SMZL that eventually underwent large B-cell lymphoma transformation. Tumor material was obtained either only at diagnosis (9 patients), at diagnosis and transformation (18 patients), and only at transformation (14 patients). Samples were categorized in 2 groups: (1) at diagnosis (SMZL, n = 27 samples), and (2) at transformation (SMZL-T, n = 32 samples). Using copy number arrays and a next-generation sequencing custom panel, we identified that the main genomic alterations in SMZL-T involved TNFAIP3, KMT2D, TP53, ARID1A, KLF2, 1q gains, and losses of 9p21.3 (CDKN2A/B) and 7q31-q32. Compared with SMZL, SMZL-T had higher genomic complexity, and higher incidence of TNFAIP3 and TP53 alterations, 9p21.3 (CDKN2A/B) losses, and 6p gains. SMZL and SMZL-T clones arose by divergent evolution from a common altered precursor cell that acquired different genetic alterations in virtually all evaluable cases (92%, 12 of 13 cases). Using whole-genome sequencing of diagnostic and transformation samples in 1 patient, we observed that the SMZL-T sample carried more genomic aberrations than the diagnostic sample, identified a translocation t(14;19)(q32;q13) present in both samples, and detected a focal B2M deletion due to chromothripsis acquired at transformation. Survival analysis showed that KLF2 mutations, complex karyotype, and International Prognostic Index score at transformation were predictive of a shorter survival from transformation (P =.001; P =.042; and P =.007; respectively). In summary, SMZL-T are characterized by higher genomic complexity than SMZL, and characteristic genomic alterations that could represent key players in the transformation event.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases

  • Carbo-Meix, Anna
  • Guijarro, Francesca|||0000-0001-6376-0929
  • Wang, Luojun
  • Grau Vorster, Marta|||0000-0003-3779-0387
  • Royo, Romina|||0000-0003-3493-0874
  • Frigola, Gerard|||0000-0001-6794-6456
  • Playa-Albinyana, Heribert
  • Buhler, Marco M.
  • Clot, Guillem|||0000-0003-2588-7413
  • Duran-Ferrer, Marti
  • Lu, Junyan
  • Granada, Isabel|||0000-0002-4275-0104
  • Baptista, Maria Joao|||0000-0003-3471-2535
  • Navarro Ferrando, José Tomás|||0000-0001-9101-6013
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Puiggros, Anna|||0000-0001-9627-4978
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Bandiera, Laura
  • De Canal, Gabriella
  • Bonoldi, Emanuela
  • Climent, Fina|||0000-0002-4360-8388
  • Ribera-Cortada, Inmaculada|||0000-0002-3372-828X
  • Fernandez-Caballero, Mariana
  • De la Banda, Esmeralda
  • Do Nascimento, Janilson
  • Pineda, Alberto
  • Vela, Dolors
  • Rozman, Maria|||0000-0002-2641-1110
  • Aymerich, Marta
  • Syrykh, Charlotte
  • Brousset, Pierre
  • Perera, Miguel
  • Yáñez, Lucrecia|||0000-0001-9925-3048
  • Ortin, Jesus Xavier
  • Tuset, Esperanza|||0000-0002-1463-6689
  • Zenz, Thorsten|||0000-0001-7890-9845
  • Cook, James R.
  • Swerdlow, Steven H.
  • Martin-Subero, Jose I.
  • Colomer, Dolors|||0000-0001-7486-8484
  • Matutes, Estella|||0000-0001-6745-7046
  • Bea, Silvia
  • Costa, Dolors|||0000-0002-8276-3292
  • Nadeu, Ferran|||0000-0003-2910-9440
  • Campo, Elias|||0000-0001-9850-9793
The t(14;19)(q32;q13) often juxtaposes BCL3 with immunoglobulin heavy chain (IGH) resulting in overexpression of the gene. In contrast to other oncogenic translocations, BCL3 rearrangement (BCL3-R) has been associated with a broad spectrum of lymphoid neoplasms. Here we report an integrative whole-genome sequence, transcriptomic, and DNA methylation analysis of 13 lymphoid neoplasms with BCL3-R. The resolution of the breakpoints at single base-pair revealed that they occur in two clusters at 5' (n=9) and 3' (n=4) regions of BCL3 associated with two different biological and clinical entities. Both breakpoints were mediated by aberrant class switch recombination of the IGH locus. However, the 5' breakpoints (upstream) juxtaposed BCL3 next to an IGH enhancer leading to overexpression of the gene whereas the 3' breakpoints (downstream) positioned BCL3 outside the influence of the IGH and were not associated with its expression. Upstream BCL3-R tumors had unmutated IGHV, trisomy 12, and mutated genes frequently seen in chronic lymphocytic leukemia (CLL) but had an atypical CLL morphology, immunophenotype, DNA methylome, and expression profile that differ from conventional CLL. In contrast, downstream BCL3-R neoplasms were atypical splenic or nodal marginal zone lymphomas (MZL) with mutated IGHV, complex karyotypes and mutated genes typical of MZL. Two of the latter four tumors transformed to a large B-cell lymphoma. We designed a novel fluorescence in situ hybridization assay that recognizes the two different breakpoints and validated these findings in 17 independent tumors. Overall, upstream or downstream breakpoints of BCL3-R are mainly associated with two subtypes of lymphoid neoplasms with different (epi)genomic, expression, and clinicopathological features resembling atypical CLL and MZL, respectively.